Zobrazeno 1 - 10
of 903
pro vyhledávání: '"Sail K"'
Autor:
Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Arslan Ö; Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkan F; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey., Herishanu Y; Department of Hematology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Ferhanoglu B; Department of Hematology, Koç University Medical Faculty, Istanbul, Turkey., Diaz MG; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Leber B; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada., Montillo M; Department of Haematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Panayiotidis P; First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Rossi D; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Skarbnik A; Lymphoproliferative Disorders Program, Novant Health Cancer Institute, Charlotte, NC, USA; John Theurer Cancer Center, Hackensack, NJ, USA., Tempescul A; Department of Clinical Hematology, University Teaching Hospital Brest, Brest, France., Turgut M; Department of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey., Mellink CH; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Kevie-Kersemaekers AF; Department of Genetics, UMC Utrecht, Utrecht, The Netherlands., Lanham S; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Sale B; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Del Rio L; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Popovic R; AbbVie, North Chicago, IL, USA., Chyla BJ; AbbVie, North Chicago, IL, USA., Busman T; AbbVie, North Chicago, IL, USA., Komlosi V; AbbVie, North Chicago, IL, USA., Wang X; AbbVie, North Chicago, IL, USA., Sail K; AbbVie, North Chicago, IL, USA., Pena GE; AbbVie, North Chicago, IL, USA., Vizkelety T; AbbVie, North Chicago, IL, USA., Forconi F; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, UK. Electronic address: f.forconi@soton.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Apr; Vol. 25 (4), pp. 463-473. Date of Electronic Publication: 2024 Mar 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shadman M; Fred Hutch Cancer Center and University of Washington, Seattle, WA., Manzoor BS; AbbVie, Inc., North Chicago, IL. Electronic address: beenish.manzoor@abbvie.com., Sail K; AbbVie, Inc., North Chicago, IL., Tuncer HH; The Cancer Center at Lowell General Hospital, Lowell, MA., Allan JN; Weill Cornell Medicine, New York, NY., Ujjani C; Fred Hutch Cancer Center and University of Washington, Seattle, WA., Emechebe N; AbbVie, Inc., North Chicago, IL., Kamalakar R; AbbVie, Inc., North Chicago, IL., Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Leslie L; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Brown JR; Dana-Farber Cancer Institute, Boston, MA., Eyre TA; Churchill Hospital, Oxford University, Oxford, UK., Rampotas A; Churchill Hospital, Oxford University, Oxford, UK., Schuh A; Churchill Hospital, Oxford University, Oxford, UK., Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Skarbnik A; Novant Health Cancer Institute, Charlotte, NC., Roeker LE; CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Bannerji R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Eichhorst B; Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University of Cologne, Cologne, Germany., Fleury I; Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada., Davids MS; Dana-Farber Cancer Institute, Boston, MA., Alhasani H; AbbVie, Inc., North Chicago, IL., Jiang D; AbbVie, Inc., North Chicago, IL., Hill BT; Cleveland Clinic, Cleveland, OH., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Brander DM; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Pivneva I; Analysis Group, Inc., Montreal, QC, Canada., Burne R; Analysis Group, Inc., Montreal, QC, Canada., Guerin A; Analysis Group, Inc., Montreal, QC, Canada., Mato AR; CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Jul; Vol. 23 (7), pp. 515-526. Date of Electronic Publication: 2023 Mar 24.
Autor:
Sehn, L. H., Wang, A., Yu, J., Kamalakar, R., Sail, K., Sinai, W., Arnette, D., Yang, S., Mutebi, A., Navarro, F. R., Salles, G.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p373-375, 3p
Autor:
Chatterjee A; OPEN Health, York, UK., van de Wetering G; OPEN Health, Rotterdam, The Netherlands., Goeree R; Goeree Consulting Ltd., Mount Hope, ON, Canada., Owen C; Foothills Medical Centre, Calgary, AB, Canada., Desbois AM; AbbVie Corporation, Saint-Laurent, QC, Canada., Barakat S; AbbVie Corporation, Saint-Laurent, QC, Canada., Manzoor BS; AbbVie Inc., North Chicago, IL, USA. beenish.manzoor@abbvie.com., Sail K; AbbVie Inc., North Chicago, IL, USA.
Publikováno v:
PharmacoEconomics - open [Pharmacoecon Open] 2023 Mar; Vol. 7 (2), pp. 199-216. Date of Electronic Publication: 2022 Nov 05.
Autor:
Miller SD; Broadstreet HEOR, 201-343 Railway St, Vancouver, BC V6A 1A4, Canada., Lozano-Ortega G; Broadstreet HEOR, 201-343 Railway St, Vancouver, BC V6A 1A4, Canada., Mutebi A; Genmab, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA., Briggs O; Genmab, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA., Sail K; AbbVie, 1 N. Waukegan Road, Chicago, IL 60064, USA., Elliott B; Genmab, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA., Kalsekar A; Genmab, 777 Scudders Mill Road, Plainsboro, NJ 08536, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2023 Jan; Vol. 12 (1), pp. e220146. Date of Electronic Publication: 2022 Nov 23.
Autor:
Sail, K., Aouici, H. aouici_hamdi@yahoo.frhamdi.aouici@enst.dz, Hassani, S.1, Fnides, B., Belaadi, A.2, Naitbouda, A.1, Abdi, S.3
Publikováno v:
International Journal of Advanced Manufacturing Technology. Oct2017, Vol. 92 Issue 9-12, p4057-4071. 15p. 9 Diagrams, 8 Charts, 3 Graphs.
Autor:
Al-Sawaf O; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Gentile B; Genentech Inc, South San Francisco, California, USA., Devine J; Genentech Inc, South San Francisco, California, USA., Zhang C; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Sail K; AbbVie Inc., North Chicago, Illinois, USA., Tandon M; Roche Products Limited, Welwyn Garden City, UK., Fink AM; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Kutsch N; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Wendtner CM; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Klinikum Schwabing, Munich, Germany., Eichhorst B; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany., Fischer K; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Sep 01; Vol. 96 (9), pp. 1112-1119. Date of Electronic Publication: 2021 Jun 22.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.